Member Info for dactions

Can’t help feeling you’re pushing a boulder up a hill Surprised.

I don’t blame you for wanting to keep the so up but the fact is that in reality, we are no further forward than we were last year or the year before. We’re not making profits and we have no better idea that this year is going to be any different.

Senior management has been rearranging the deckchairs on the Titanic !

Any fool can win a contract - it takes a businessman/woman to win it showing a profit.

It's been over 3 years since the placing at 6.5p and where are we ? Don't blame it on Covid, consider some of the acquisitions along the way, the high salaries being paid to 'consultants' not least the whopper paid to Phil Cartmell. The sp may indeed recover, I hope so - I will offload then.

Well last night I had hoped for a turn in the group’s performance but that was a naive thought. I am disappointed by yet further losses with a further contraction of the balance sheet. It’s difficult to see through the spin what the real state of the business is.

Really hoping that this time we'll see an RNS with real profits.

Aurelien is a Clinical Pharmacist in Intensive Care - so he's right at the coal-face and so will be well worth watching for his tweets from Amiens, France.

Joey - I think Monsieur Aurelien Mary is a research pharmacist (so not sure about the Dr. title) but I was sure he had referred to SNG in a earlier tweet in the summer (as he has been positively pushing for this chance).

Today he tweets (english translation) : The regional council has chosen to finance a trial at the Amiens University Hospital on the use of inhaled interferon. .. . . . and another tweet: Thank you very much to the regional council for its support for the clinical trial evaluating the role of inhaled IFNb in tt of covid19..

https://twitter.com/MARYau_MCU_PH/status/1318119934296248320

Elrico - I do appreciate the recent Opti podcast and detailed discussion with SoH. We've been saying it for a long time that it's only a matter of time to see good trading results but surely that time must be nearer now.

A tip by TW ?
Curious though, that this morning also saw a couple of large sales totalling 2 million shares !

Just bringing this to the top.

Wasn't it a recent tweet from this Research Pharmacist that pointed to some possible good news today from the EMA meeting ?

There was a recent tweet from Aurelien Mary that gave rise to the thought that SNG001 would be available as an emergency treatment within France. Looking at this man's background in Pharmacy and treatment research, he is more knowledgeable than we might have thought. See this link where he was clearly positive about inhaled Interferon Beta as early as April:
It's in French but he is clearly talking about SNG - check 1 min in.

https://www.youtube.com/watch?v=0TXfCAORf7Q&list=PLbrnrfMhTABDcivdS4UJ5-r18WIvAVML0&index=15&t=0s&app=desktop

Some good news to add to the positive RNS tonight. I would have liked the placing price to be £2 rather than 175p but I'm confident that whatever tomorrow brings, we'll be OK by the new year which is only 10 weeks away !

I want to see some decent results come the 20th irrespective of 2020 being a 'covid' year.
I don't want the Board using this as an excuse.

Shareholders have not featured at all in the Board's announcements in recent years. We've had some loss of Institutional Investors. A substantial placing was made more than 3 years ago now, I added quite substantially then and shareholders are entitled to see a return on their capital at some stage or what is the point ? We're not providing a social service and management, particularly Mr. Phil Cartmel are doing very well out of the company.

We've been drip fed regular notice of contract wins but clearly they've been insufficient to date - are they building on a profitable base and enhancing capital or are they finding work for the staff ? So far, in my opinion, they've clearly been work fillers - it's time for Management to prove themselves.

Some interesting spikes - thanks Joey

THanks Joey - I had certainly missed the connections. Much appreciated.

Can someone expand on the significance of the 15th October and how it relates to SNG ?

Could there be any significance with 3 large buys this week. Thursday two buys of £16k and £13.5k and Tuesday one of £25k. I don't think we've seen any buys of this size in a very long time.

The just published report from Edison research makes interesting reading - they've upped their captial valuation from £107m to a much higher figure of now £170m which reminds me of valuations they were making for RENE 4/5 years ago - remembering it's only £33m at present.

Unlike previous reports, there is some good material on RENE's competitors both in treatment for Retinitus Pigmentosa and also for Exosomes. One dispiriting factor and probably is why there has been a drip drip lowering in sp value these past months - and that is the ever pushing further into the future the likelihood of achieving earnings for shareholders.

Here is the link:
https://www.edisongroup.com/wp-content/uploads/2020/08/ReNeuron-Group-Exploiting-the-potential-of-cell-therapy.pdf

I too like the quality of the acquisition if there website is anything to go by - as they go, it's one of the best I've ever seen (and I concur re. the sentiment expressed about inspiring youngsters to aviation).

However, it's not the website we're acquiring but some pricey consultants - and if anyone needs reminding, we're in a serious pandemic especially when it comes to the aviation industry - there's trouble everywhere you look. With the big aviation hubs - eg. Gatwick says the 2nd runway is off the table and the smaller UK airports - Southend is losing EasyJet. The airlines are laying off pilots, the makers are shelving new plane plans - so where's the income going to come from ?

TPG's shareprice has been weak for quite some time - and selling recently would at best have got you 6.5p which is exactly the sum that the company raised at, 3 whole years ago.

I don't think this acquisition is going to change sentiment - real profit is all that will do it in my opinion.

. . . how good the new website looks ?
. . . and the excellent price positioning ?

It's been a while since I last looked at CPT despite having a holding from the 4p placing some years ago. I'd written this investment off, but only now, this past week, re-looked at their business module following change of direction with the new top female management - and it looks very good indeed.

Others have questioned their concerns on re-branding and whether mylo would achieve good ranking in google for example - but it does - although they are also paying at the moment for name placement in Google ! But even so, they've cleverly changed their products domain to myloworld.com which I believe is one of the key factors in website ranking.

The new kit is supposedly on sale price from £149 inc vat to £99 inc. To my mind this was always where the price should be to get something so novel off the ground - by all means rely more on follow-on sales for the Luteinising Hormone and Pregnancy test tabs to make up the margins.

Reading the website text and blog seems very empathetic and if the rest of the business is as equally well done then there's every chance they can at last get this business moving forward at the pace it deserves.

Cash at 2019 y/e was £620,000 and they raised £1.9m in April so finance is taken care of this year and at these lower product price levels sales volume should now be increasing. I have no knowledge though as to how the BOOTS sales are going - making enquiries at various local stores got me nowhere and I'm hoping this it' online sales that are leading the way. I would expect to hear soon how the first half has traded. But right now, I'm much more optimistic that a share re-rating is possible and we'll recover some of the historic sp lost ground.

As far as I can tell, Concepta has a unique product here in both its technical prowess and now it's very competitive price structure. If they get the press momentum going , then at these prices the product should fly.

If it cheers you up Oggy70 and ensure you get a good night's sleep another £1 ;-)

In this trial, the talk is of interferon beta-1a but then the link as I understood it for Multiple Sclerosis is interferon beta-1b. My Wife, who has secondary progressive multiple sclerosis, was turned down for a trial, because the Neurological Hospital in Russel Square, London were seeking younger participants - but only 'interferon beta' was then discussed - I've never understood the differences between the different types.